DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Sato A. et al.
Valvular heart disease as a possible predictor of trastuzumab‑induced cardiotoxicity in patients with breast cancer.
Molecular and Clinical Oncology 2019;
10 p 37-42
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.